Article
Publicly Available
Frontmatter
Published/Copyright:
April 1, 2017
Published Online: 2017-4-1
Published in Print: 2017-5-1
©2017 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Not all good things come in big packages
- Pre-analytical and Analytical Issues of miRNA Measurement
- Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs
- Pitfalls of analysis of circulating miRNA: role of hematocrit
- Intraindividual variation of microRNA expression levels in plasma and peripheral blood mononuclear cells and the associations of these levels with the pathogenesis of autoimmune thyroid diseases
- miRNA assays in the clinical laboratory: workflow, detection technologies and automation aspects
- Clinical Applications of the Different Circulating Forms of miRNAs
- The role of extracellular vesicle microRNAs in cancer biology
- The clinical significance of platelet microparticle-associated microRNAs
- microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application
- microRNAs in cardiovascular disease – clinical application
- miRNAs in Cancer
- Non-coding RNAs: the cancer genome dark matter that matters!
- miRNAs as novel biomarkers in the management of prostate cancer
- Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients
- Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma
- miRNA analysis in pancreatic cancer: the Dartmouth experience
- miRNAs and Genomic
- miRNAs, single nucleotide polymorphisms (SNPs) and age-related macular degeneration (AMD)
Articles in the same Issue
- Frontmatter
- Editorial
- Not all good things come in big packages
- Pre-analytical and Analytical Issues of miRNA Measurement
- Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs
- Pitfalls of analysis of circulating miRNA: role of hematocrit
- Intraindividual variation of microRNA expression levels in plasma and peripheral blood mononuclear cells and the associations of these levels with the pathogenesis of autoimmune thyroid diseases
- miRNA assays in the clinical laboratory: workflow, detection technologies and automation aspects
- Clinical Applications of the Different Circulating Forms of miRNAs
- The role of extracellular vesicle microRNAs in cancer biology
- The clinical significance of platelet microparticle-associated microRNAs
- microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application
- microRNAs in cardiovascular disease – clinical application
- miRNAs in Cancer
- Non-coding RNAs: the cancer genome dark matter that matters!
- miRNAs as novel biomarkers in the management of prostate cancer
- Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients
- Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma
- miRNA analysis in pancreatic cancer: the Dartmouth experience
- miRNAs and Genomic
- miRNAs, single nucleotide polymorphisms (SNPs) and age-related macular degeneration (AMD)